Patents Assigned to SALIVATECH CO., LTD.
  • Publication number: 20190250164
    Abstract: Salivary biomarker characterized as low-molecular-weight compounds named metabolites or combinations of these biomarkers are used for detecting cancers. The salivary biomarker for cancer can be, for example, a combination of creatinine, N1-acetylspermidine, ?-aminoadipic acid, N-acetylneuraminic acid, and 1,3-diaminopropane. Due to this configuration, the early detection of pancreatic cancer, breast cancer, oral cancer, and the like is possible in a healthy subject even with saliva having large concentration fluctuations.
    Type: Application
    Filed: April 24, 2019
    Publication date: August 15, 2019
    Applicant: SALIVATECH CO. , LTD.
    Inventors: Masahiro SUGIMOTO, Tomoyoshi SOGA, Makoto SUNAMURA
  • Publication number: 20160282351
    Abstract: Salivary biomarker characterized as low-molecular-weight compounds named metabolites or combinations of these biomarkers are used for detecting cancers. The salivary biomarker for cancer can be, for example, a combination of creatinine, N1-acetylspermidine, ?-aminoadipic acid, N-acetylneuraminic acid, and 1,3-diaminopropane. Due to this configuration, the early detection of pancreatic cancer, breast cancer, oral cancer, and the like is possible in a healthy subject even with saliva having large concentration fluctuations.
    Type: Application
    Filed: October 28, 2014
    Publication date: September 29, 2016
    Applicant: SALIVATECH CO., LTD.
    Inventors: Masahiro SUGIMOTO, Tomoyoshi SOGA, Makoto SUNAMURA